Last reviewed · How we verify
Laif® 900, BAY98-7108 — Competitive Intelligence Brief
phase 3
Herbal antidepressant / Phytopharmaceutical
Serotonin transporter (SERT), norepinephrine transporter (NET), dopamine transporter (DAT)
Psychiatry / Mental Health
Small molecule
Live · refreshed every 30 min
Target snapshot
Laif® 900, BAY98-7108 (Laif® 900, BAY98-7108) — Bayer. Laif 900 is a standardized St. John's Wort extract that modulates serotonin and other neurotransmitter systems to improve mood in depression.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Laif® 900, BAY98-7108 TARGET | Laif® 900, BAY98-7108 | Bayer | phase 3 | Herbal antidepressant / Phytopharmaceutical | Serotonin transporter (SERT), norepinephrine transporter (NET), dopamine transporter (DAT) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Herbal antidepressant / Phytopharmaceutical class)
- Bayer · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Laif® 900, BAY98-7108 CI watch — RSS
- Laif® 900, BAY98-7108 CI watch — Atom
- Laif® 900, BAY98-7108 CI watch — JSON
- Laif® 900, BAY98-7108 alone — RSS
- Whole Herbal antidepressant / Phytopharmaceutical class — RSS
Cite this brief
Drug Landscape (2026). Laif® 900, BAY98-7108 — Competitive Intelligence Brief. https://druglandscape.com/ci/laif-900-bay98-7108. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab